• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • 2026 Election
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
    • Examining Transportation
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
Advertisement
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • 2026 Election
  • America at 250
  • IN FOCUS
  • Commentary
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
    • Examining Transportation
  • Newsletters
More
    Advertisement
    Home › Tags › Posts tagged Pharmaceutical Industry

    Tag: Pharmaceutical Industry

    Democrats accuse multiple sclerosis drugmakers of ‘shadow pricing’ Healthcare

    Democrats accuse multiple sclerosis drugmakers of ‘shadow pricing’

    Robert King · August 17, 2017 3:15 pm
    Speedy drug approvals lacking in follow-up Healthcare

    Speedy drug approvals lacking in follow-up

    Robert King · August 16, 2017 8:39 pm
    South Carolina sues Oxycontin maker Healthcare

    South Carolina sues Oxycontin maker

    Robert King · August 15, 2017 3:31 pm
    Martin Shkreli: I was targeted for being ‘flamboyant and personable’ Crime

    Martin Shkreli: I was targeted for being ‘flamboyant and personable’

    Pete Kasperowicz · August 15, 2017 1:06 pm
    Advertisement
    The Trump bump: Merck shares rise after tweet Healthcare

    The Trump bump: Merck shares rise after tweet

    Kimberly Leonard · August 14, 2017 3:15 pm
    Trump slams Merck’s ‘ripoff drug prices’ after CEO resigns from manufacturing council News

    Trump slams Merck’s ‘ripoff drug prices’ after CEO resigns from manufacturing council

    Melissa Quinn · August 14, 2017 1:11 pm
    New Hampshire sues opioid makers for deceptive marketing Healthcare

    New Hampshire sues opioid makers for deceptive marketing

    Kimberly Leonard · August 9, 2017 3:39 pm
    Martin Shkreli leaves a legacy on Capitol Hill Crime

    Martin Shkreli leaves a legacy on Capitol Hill

    Robert King · August 5, 2017 12:22 am
    Advertisement
    ‘Pharma Bro’ Martin Shkreli found guilty of securities fraud Healthcare

    ‘Pharma Bro’ Martin Shkreli found guilty of securities fraud

    Robert King · August 4, 2017 6:52 pm
    Senate passes FDA funding package Healthcare

    Senate passes FDA funding package

    Robert King · August 3, 2017 4:47 pm
    Senate passes bill to give terminally ill patients access to experimental drugs Healthcare

    Senate passes bill to give terminally ill patients access to experimental drugs

    Robert King · August 3, 2017 4:18 pm
    Medicare Part D premiums set to drop next year Healthcare

    Medicare Part D premiums set to drop next year

    Robert King · August 2, 2017 9:43 pm
    Advertisement
    • ‹Previous page
    • 1
    • …
    • 95
    • 96
    • 97
    • 98
    • 99
    • …
    • 138
    • ›Next page
    Page 97 of 138
    Advertisement
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter
    • © Copyright 2026. Washington Examiner. All Rights Reserved.